Wednesday Oct 08, 2025

Blarcamesine Demonstrates Promising Outcomes in Alzheimer’s Treatment Trial

Anavex Life Sciences has announced promising findings from their Phase 2b/3 trial of blarcamesine, a novel therapeutic candidate for early Alzheimer’s disease (AD). The investigational drug, also known as ANAVEX2-73, by Anavex, showed significant efficacy in reducing amyloid-ß biomarkers and slowing cognitive decline in patients.  The multicenter, randomized, double-blind, placebo-controlled study involved 508 participants from […]

Michael Polk: Revolutionizing Marketing Strategies with Innovation

Michael Polk, president of Unilever United States, recently delivered an impactful speech at the Wharton Marketing Conference. Emphasizing the difference between invention and innovation, Polk argued that successful marketing hinges on the latter.  Polk’s leadership at Unilever involves overseeing well-known brands such as Dove, Axe, and Lipton. His approach centers on “dislocating ideas,” concepts that […]

Naftali Zanziper: Spearheading Multimillion-Dollar Real Estate Acquisitions

Few names have recently garnered as much attention in the dynamic world of real estate investment as Naftali Zanziper. As a key figure in the Portopiccolo Group, Zanzibar has been at the forefront of significant property acquisitions, reshaping the landscape of multifamily housing investments. The Portopiccolo Group, a family office headquartered in Englewood Cliffs, New […]

Back to Top